Steven F Ethridge

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. pmc Performance of the Aptima HIV-1 RNA qualitative assay with 16- and 32-member specimen pools
    Steven F Ethridge
    Centers for Disease Control and Prevention, Division of HIV AIDS Prevention, 1600 Clifton Road, Mailstop E 46, Atlanta, GA 30333, USA
    J Clin Microbiol 48:3343-5. 2010
  2. doi request reprint Performance of an alternative laboratory-based algorithm for diagnosis of HIV infection utilizing a third generation immunoassay, a rapid HIV-1/HIV-2 differentiation test and a DNA or RNA-based nucleic acid amplification test in persons with established H
    Laura G Wesolowski
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd, NE MS E 46, Atlanta, GA 30333, USA
    J Clin Virol 52:S45-9. 2011
  3. pmc Repeat confirmatory testing for persons with discordant whole blood and oral fluid rapid HIV test results: findings from post marketing surveillance
    Laura G Wesolowski
    Division of HIV AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    PLoS ONE 3:e1524. 2008
  4. doi request reprint Comparative evaluation of Aptima HIV-1 Qualitative RNA assay performance using plasma and serum specimens from persons with established HIV-1 infection
    Steven F Ethridge
    Division of HIV AIDS Prevention, National Center for HIV, Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd MS E46, Atlanta, GA 30333, USA
    J Clin Virol 52:S63-6. 2011
  5. pmc HIV screening practices in U.S. hospitals, 2009-2010
    Andrew C Voetsch
    Centers for Disease Control and Prevention, Division of HIV AIDS Prevention, Atlanta, GA 30333, USA
    Public Health Rep 127:524-31. 2012
  6. doi request reprint Evaluation of supplemental testing with the Multispot HIV-1/HIV-2 Rapid Test and APTIMA HIV-1 RNA Qualitative Assay to resolve specimens with indeterminate or negative HIV-1 Western blots
    Laurie Linley
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, United States Electronic address
    J Clin Virol 58:e108-12. 2013
  7. doi request reprint Costs and outcomes of laboratory diagnostic algorithms for the detection of HIV
    Angela B Hutchinson
    Centers for Disease Control and Prevention, Atlanta, GA, United States Electronic address
    J Clin Virol 58:e2-7. 2013
  8. doi request reprint Comparison of alternative interpretive criteria for the HIV-1 Western blot and results of the Multispot HIV-1/HIV-2 Rapid Test for classifying HIV-1 and HIV-2 infections
    Muazzam Nasrullah
    Division of HIV AIDS Prevention, National Center for HIV, Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Mailstop E46, Atlanta, GA 30333, USA
    J Clin Virol 52:S23-7. 2011
  9. pmc Rapid human immunodeficiency virus test quality assurance practices and outcomes among testing sites affiliated with 17 public health departments
    Laura G Wesolowski
    Division of HIV AIDS Prevention, National Center for HIV AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Clin Microbiol 47:3333-5. 2009
  10. ncbi request reprint Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing
    Laura G Wesolowski
    Division of HIV AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    AIDS 20:1661-6. 2006

Collaborators

Detail Information

Publications10

  1. pmc Performance of the Aptima HIV-1 RNA qualitative assay with 16- and 32-member specimen pools
    Steven F Ethridge
    Centers for Disease Control and Prevention, Division of HIV AIDS Prevention, 1600 Clifton Road, Mailstop E 46, Atlanta, GA 30333, USA
    J Clin Microbiol 48:3343-5. 2010
    ..The Aptima test can be used to screen for acute-phase HIV infection...
  2. doi request reprint Performance of an alternative laboratory-based algorithm for diagnosis of HIV infection utilizing a third generation immunoassay, a rapid HIV-1/HIV-2 differentiation test and a DNA or RNA-based nucleic acid amplification test in persons with established H
    Laura G Wesolowski
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd, NE MS E 46, Atlanta, GA 30333, USA
    J Clin Virol 52:S45-9. 2011
    ..An alternative diagnostic algorithm has been proposed to detect early HIV-1 infection and differentiate HIV-1 from HIV-2...
  3. pmc Repeat confirmatory testing for persons with discordant whole blood and oral fluid rapid HIV test results: findings from post marketing surveillance
    Laura G Wesolowski
    Division of HIV AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    PLoS ONE 3:e1524. 2008
    ..Previous reports have not described whether repeat testing adequately resolves the HIV-infection status of persons with discordant results...
  4. doi request reprint Comparative evaluation of Aptima HIV-1 Qualitative RNA assay performance using plasma and serum specimens from persons with established HIV-1 infection
    Steven F Ethridge
    Division of HIV AIDS Prevention, National Center for HIV, Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd MS E46, Atlanta, GA 30333, USA
    J Clin Virol 52:S63-6. 2011
    ....
  5. pmc HIV screening practices in U.S. hospitals, 2009-2010
    Andrew C Voetsch
    Centers for Disease Control and Prevention, Division of HIV AIDS Prevention, Atlanta, GA 30333, USA
    Public Health Rep 127:524-31. 2012
    ..In 2006, the Centers for Disease Control and Prevention (CDC) recommended HIV screening for all individuals 13-64 years of age in health-care settings. We determined the frequency of hospital adoption of these CDC recommendations...
  6. doi request reprint Evaluation of supplemental testing with the Multispot HIV-1/HIV-2 Rapid Test and APTIMA HIV-1 RNA Qualitative Assay to resolve specimens with indeterminate or negative HIV-1 Western blots
    Laurie Linley
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, United States Electronic address
    J Clin Virol 58:e108-12. 2013
    ..The use of Western blot (WB) as a supplemental test after reactive sensitive initial assays can lead to inconclusive or misclassified HIV test results, delaying diagnosis...
  7. doi request reprint Costs and outcomes of laboratory diagnostic algorithms for the detection of HIV
    Angela B Hutchinson
    Centers for Disease Control and Prevention, Atlanta, GA, United States Electronic address
    J Clin Virol 58:e2-7. 2013
    ..While it promises greater sensitivity, it also raises concerns about costs...
  8. doi request reprint Comparison of alternative interpretive criteria for the HIV-1 Western blot and results of the Multispot HIV-1/HIV-2 Rapid Test for classifying HIV-1 and HIV-2 infections
    Muazzam Nasrullah
    Division of HIV AIDS Prevention, National Center for HIV, Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Mailstop E46, Atlanta, GA 30333, USA
    J Clin Virol 52:S23-7. 2011
    ..HIV-1 and HIV-2 infections may be identified using assays designed to differentiate HIV-1 and HIV-2 antibody reactivity...
  9. pmc Rapid human immunodeficiency virus test quality assurance practices and outcomes among testing sites affiliated with 17 public health departments
    Laura G Wesolowski
    Division of HIV AIDS Prevention, National Center for HIV AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Clin Microbiol 47:3333-5. 2009
    ..Rapid tests (n = 86,749) were generally conducted according to manufacturers' instructions, but ongoing testing competency assessments and on-site QA monitoring were not uniformly conducted...
  10. ncbi request reprint Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing
    Laura G Wesolowski
    Division of HIV AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    AIDS 20:1661-6. 2006
    ..Post-marketing surveillance was conducted to monitor the performance of the OraQuick Advance rapid HIV-1/2 antibody test (OraQuick) on whole blood and oral fluid...